|
1
|
Vander Heiden MG: Targeting cancer
metabolism: a therapeutic window opens. Nat Rev Drug Discov.
10:671–684. 2011.PubMed/NCBI
|
|
2
|
Jones NP and Schulze A: Targeting cancer
metabolism - aiming at a tumor’s sweet-spot. Drug Discov Today.
17:232–241. 2012.PubMed/NCBI
|
|
3
|
Hamanaka RB and Chandel NS: Targeting
glucose metabolism for cancer therapy. J Exp Med. 209:211–215.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goldberg MS and Sharp PA: Pyruvate kinase
M2-specific siRNA induces apoptosis and tumor regression. J Exp
Med. 209:217–224. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olivares M and Uauy R: Copper as an
essential nutrient. Am J Clin Nutr. 63:S791–S796. 1996.
|
|
6
|
Uauy R, Olivares M and Gonzalez M:
Essentiality of copper in humans. Am J Clin Nutr. 67(5 Suppl):
S952–S959. 1998.
|
|
7
|
Theophanides T and Anastassopoulou J:
Copper and carcinogenesis. Crit Rev Oncol Hematol. 42:57–64. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Finney L, Vogt S, Fukai T and Glesne D:
Copper and angiogenesis: unravelling a relationship key to cancer
progression. Clin Exp Pharmacol Physiol. 36:88–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tisato F, Marzano C, Porchia M, Pellei M
and Santini C: Copper in diseases and treatments, and copper-based
anticancer strategies. Med Res Rev. 30:708–749. 2010.PubMed/NCBI
|
|
10
|
Margalioth EJ, Schenker JG and Chevion M:
Copper and zinc levels in normal and malignant tissues. Cancer.
5:868–872. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diez M, Arroyo M, Cerdan FJ, Munoz M,
Martin MA and Balibrea JL: Serum and tissue trace metal levels in
lung cancer. Oncology. 4:230–234. 1989.PubMed/NCBI
|
|
12
|
Peng F, Lu X, Janisse J, Muzik O and
Shields AF: PET of human prostate cancer xenografts in mice with
increased uptake of 64CuCl2. J Nucl Med.
47:1649–1652. 2006.PubMed/NCBI
|
|
13
|
Zhang H, Cai H, Lu X, Muzik O and Peng F:
Positron emission tomography of human hepatocellular carcinoma
xenografts in mice using copper (II)-64 chloride as a tracer. Acad
Radiol. 18:1561–1568. 2011. View Article : Google Scholar
|
|
14
|
Puig S and Thiele DJ: Molecular mechanisms
of copper uptake and distribution. Curr Opin Chem Biol. 6:171–180.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lutsenko S: Human copper homeostasis: a
network of interconnected pathways. Curr Opin Chem Biol.
14:211–217. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Klomp LW, Lin SJ, Yuan DS, Klausner RD,
Culotta VC and Gitlin JD: Identification and functional expression
of HAH1, a novel human gene involved in copper homeostasis. J Biol
Chem. 272:9221–9226. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Culotta VC, Klomp LW, Strain J, Casareno
RL, Krems B and Gitlin JD: The copper chaperone for superoxide
dismutase. J Biol Chem. 272:23469–23472. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rae TD, Schmidt PJ, Pufahl RA, Culotta VC
and O’Halloran TV: Undetectable intracellular free copper: the
requirement of a copper chaperone for superoxide dismutase.
Science. 284:805–808. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Punter FA, Adams DL and Glerum DM:
Characterization and localization of human COX17, a gene involved
in mitochondrial copper transport. Hum Genet. 107:69–74. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki C, Daigo Y, Kikuchi T, Katagiri T
and Nakamura Y: Identification of COX17 as a therapeutic target for
non-small cell lung cancer. Cancer Res. 63:7038–7041.
2003.PubMed/NCBI
|
|
21
|
Itoh S, Kim HW, Nakagawa O, Ozumi K,
Lessner SM, Aoki H, et al: Novel role of antioxidant-1 (Atox1) as a
copper-dependent transcription factor involved in cell
proliferation. J Biol Chem. 283:9158–9167. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Muller PA and Klomp LW: ATOX1: a novel
copper-responsive transcription factor in mammals? Int J Biochem
Cell Biol. 41:1233–1236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sui G, Soohoo C, Affar EB, Gay F,
Forrester WC and Shi Y: A DNA vector-based RNAi technology to
suppress gene expression in mammalian cells. Proc Natl Acad Sci
USA. 99:5515–5520. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brummelkamp TR, Bernards R and Agami R:
Stable suppression of tumorigenicity by virus-mediated RNA
interference. Cancer Cell. 2:243–247. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang H, Ronald Thomas R, Oupicky D and
Peng F: Synthesis and characterization of new copper
thiosemicarbazone complexes with an ONNS quadridentate system: cell
growth inhibition, S-phase cell cycle arrest and proapoptotic
activities in the cisplatin-resistant neuroblastoma cells. J Biol
Inorg Chem. 13:47–55. 2008. View Article : Google Scholar
|
|
26
|
Qiu Q, Jiang JY, Bell M, Tsang BK and
Gruslin A: Activation of endoproteolytic processing of insulin-like
growth factor-II in fetal, early postnatal, and pregnant rats and
persistence of circulating levels in postnatal life. Endocrinology.
148:4803–4811. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van de Loosdrecht AA, Beelen RH,
Ossenkoppele GJ, Broekhoven MG and Langenhuijsen MM: A
tetrazolium-based colorimetric MTT assay to quantitate human
monocyte mediated cytotoxicity against leukemic cells from cell
lines and patients with acute myeloid leukemia. J Immunol Methods.
174:311–320. 1994.
|
|
28
|
Mangala LS, Zuzel V, Schmandt R, Leshane
ES, Halder JB, Armaiz-Pena GN, et al: Therapeutic targeting of
ATP7B in ovarian carcinoma. Clin Cancer Res. 15:3770–3780. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheung BB and Marshall GM: Targeting ATP7A
to increase the sensitivity of neuroblastoma cells to retinoid
therapy. Curr Cancer Drug Targets. 11:826–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
